Idorsia anticipates lower operating loss, sees share drop amid funding search By Investing.com
© Reuters.
Swiss biopharmaceutical company, Idorsia, experienced a 13% drop in shares on Tuesday while it continues to pursue additional funding. This comes despite the company's efforts to secure liquidity through Q1 2024, which…
